Sort
48,018 grants matching “immunotherapy”
Antigenic determinants of asthma-associated allergens for design of immunotherapy.
$470,045Anna Pomes · Indoor Biotechnologies · R01 · FY2015 · AI
Radioluminescence dosimetry solution for precision radiation therapy
$470,043Lei Xing · Stanford University · R01 · FY2022 · CA
Immunological Priming to Hepatitis B Virus
$470,003Masanori Isogawa · Scripps Research Institute, The · R01 · FY2010 · AI
Strategies to Enhance Lymphoid Recovery After Radiation-Induced Injury
$470,003Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2010 · AI
Bacterial Quorum Sensing as Target for Anti-Infective Immunotherapy
$470,003Gunnar Joerg Floris Kaufmann · Scripps Research Institute, The · R01 · FY2010 · AI
Role of Integrins in Natural Killer Cell Function
$469,962Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM
$469,956Sangeeta Goswami · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM
$469,956Sangeeta Goswami · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Customized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumors
$469,913Vanessa Bellat · Weill Medical Coll Of Cornell Univ · R37 · FY2024 · CA
AHR-mediated immunosuppression in glioblastoma
$469,890Francisco J. Quintana · Brigham And Women'S Hospital · R01 · FY2023 · ES
Biomimetic Matrix for Ex Vivo and In Vivo Activation of T Cells
$469,854Hai-Quan Mao · Johns Hopkins University · R01 · FY2021 · EB
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
$469,848Xiao-Fan Wang · Duke University · R01 · FY2021 · CA
B. anthracis:passive immunization with anticapsular mAb
$469,832Thomas R Kozel · University Of Nevada Reno · R01 · FY2006 · AI
Health-associated oral bacteria as anti-cancer and immunomodulatory agents in oral cancer
$469,830Nezar Al-Hebshi · Temple Univ Of The Commonwealth · R21 · FY2024 · DE
The role of IL-27/Lag3 axis in regulating Foxp3+ regulatory T cell function
$469,818Booki Min · Northwestern University At Chicago · R01 · FY2024 · AI
Pathogenesis of EBV Infection
$469,785Frederick C. Wang · Brigham And Women'S Hospital · R01 · FY2010 · CA
Targeting through Selective Cell Labeling
$469,752Jianjun Cheng · University Of Illinois At Urbana-Champaign · R01 · FY2019 · EB
Preclinical Evaluation of Anti-Fibrin Immunotherapy for Cerebral ALD: Leveraging a Novel Mouse Model to Guide Clinical Trial Design
$469,622Keith Van Haren · Stanford University · R21 · FY2025 · NS
Pre-clinical testing of a novel immunotherapy [recombinant T cell receptor ligand
$469,568Jennifer M Loftis · Oregon Health & Science University · RC1 · FY2010 · DA
Developing new therapeutic strategies for pediatric tumors that lack clinically actionable mutations
$469,566Paul Geeleher · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Developing new therapeutic strategies for pediatric tumors that lack clinically actionable mutations
$469,566Paul Geeleher · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
$469,554Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Unravel the novel role of S100A7 and its functional partners in Metastatic Triple Negative Breast Cancer Racial Disparity
$469,544Ramesh K Ganju · Ohio State University · R01 · FY2025 · CA
Unravel the novel role of S100A7 and its functional partners in Metastatic Triple Negative Breast Cancer Racial Disparity
$469,544Ramesh K Ganju · Ohio State University · R01 · FY2024 · CA
CAREER: Mathematical Framework for Elucidating Mechanics at Immune Cell Interfaces
$469,420Jun Allard · University Of California-Irvine · · FY2015 · MPS